Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Ganoderic acid C2 | Ganoderic acid C2 is a triterpenoid compound found in the fruit body of Ganoderma lucidum. Ganoderic Acid C2 exhibits inhibitory effect on tumor and inflammations. Group: Pharmaceutical. Alternative Names: Lanost-8-en-26-oic acid, 3,7,15-trihydroxy-11,23-dioxo-, (3β,7β,15α,25R)-; (3β,7β,15α,25R)-3,7,15-Trihydroxy-11,23-dioxolanost-8-en-26-oic acid; Ganoderic acid C 2; (2R,6R)-2-methyl-4-oxo-6-((3S,5R,7S,10S,13R,14R,15S,17R)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid. CAS No. 103773-62-2. Pack Sizes: 5 mg. Product ID: B0005-159387. Molecular formula: C30H46O7. Mole weight: 518.68. Custom synthesis is available. Send your inquiries for more information. |  London |
| 20(21)-Dehydrolucidenic acid A | 20(21)-Dehydrolucidenic acid A is a triterpenoid compound found in the fruit body of Ganoderma lucidum. Group: Pharmaceutical. Alternative Names: 4-[(5R,7S,10S,13R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pent-4-enoic acid. CAS No. 852936-69-7. Pack Sizes: 5 mg. Product ID: B0005-053714. Molecular formula: C27H36O6. Mole weight: 456.579. Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid A | Lucidenic acid A, a naturally occurring compound found in Ganoderma lucidum fruiting bodies, displays immense therapeutic potential. It exhibits anti-inflammatory, anti-tumor, and anti-diabetic properties as evidenced by various studies. Additionally, it significantly impacts physiological parameters such as blood pressure, cholesterol, and blood sugar. The multifaceted activities of Lucidenic acid A render it an ideal candidate for treating chronic inflammatory diseases, diabetes, and cancer. Group: Pharmaceutical. Alternative Names: lucidenic acid A; 95311-94-7; LucidenicacidA; Lucideric acid A; (4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid; CHEMBL460969; SCHEMBL6522668; CHEBI:172690; DTXSID401316662; HY-N6862; BDBM50356926; AKOS037515140; AC-34115; MS-28395; CS-0027808; D85042; 7beta-hydroxy-4,4,14alpha-trimethyl-3,11,15-trioxo-5alpha-chol-8-en-24-oic acid. CAS No. 95311-94-7. Pack Sizes: 20 mg. Product ID: B0005-465653. Molecular formula: C27H38O6. Mole weight: 458.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid B | Lucidenic acid B, an organic compound hailing from Ganoderma lucidum, is praised for its multifaceted biomedical properties. From combating neoplasms to alleviating inflammations, this natural triterpenoid holds great promise in treating debilitating conditions such as breast and prostate cancers and an array of inflammatory disorders. Group: Pharmaceutical. Alternative Names: Lucidenic acid B; (5alpha,7beta,12beta)-7,12-Dihydroxy-4,4,14-trimethyl-3,11,15-trioxo-chol-8-en-24-oic acid. CAS No. 95311-95-8. Pack Sizes: 10 mg. Product ID: B0005-465654. Molecular formula: C27H38O7. Mole weight: 474.58642. Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid C | Lucidenic acid C, an organic compound derived from the fungus Ganoderma lucidum, exhibits multifaceted pharmacological actions such as antioxidant, anti-inflammatory, immunomodulatory, and anticancer properties. Novel studies have elucidated that this naturally occurring triterpene exhibits profound inhibition of malignancy development and metastasis in cancer cells. The promising therapeutic potential of lucidenic acid C extends beyond oncology, offering a plethora of therapeutic applications in diverse pathological conditions. Group: Pharmaceutical. Alternative Names: Lucidenic acid C; (3beta,5alpha,7beta,12beta)-3,7,12-Trihydroxy-4,4,14-trimethyl-11,15-dioxo-chol-8-en-24-oic acid. CAS No. 95311-96-9. Pack Sizes: 10 mg. Product ID: B0005-465650. Molecular formula: C27H40O7. Mole weight: 476.6023. Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid D | Lucidenic acid D, a triterpenoid compound, is extracted from Ganoderma lucidum and is reported to be endowed with multifarious biological activities, such as anti-cancer, anti-inflammatory, and antioxidant properties. With its remarkable potential to stimulate apoptosis in cancer cells, lucidenic acid D stands out as an effective therapeutic candidate for combating cancer and other ailments. Group: Pharmaceutical. Alternative Names: Lucidenic acid D; Lucidenic acid D; 298665-16-8; LucidenicacidD; UNII-4C2000605T. CAS No. 98665-16-8. Pack Sizes: 10 mg. Product ID: NP7070. Molecular formula: C29H38O8. Mole weight: 514.61. Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid E | Lucidenic acid E, a triterpenoid derived from Ganoderma lucidum, exhibits potent anti-inflammatory, anti-tumor and anti-diabetic activities. Notably, it has demonstrated the ability to impede in vitro cancer cell growth, indicating its potential therapeutic value. Its hepatoprotective and antioxidant effects further increase the promise of lucidenic acid E in the treatment of liver ailments. Such multifaceted properties of this natural compound highlight its potential in the development of novel therapies. Group: Pharmaceutical. Alternative Names: Lucidenic Acid E2; Lucidenic acid E. CAS No. 98665-17-9. Pack Sizes: 5 mg. Product ID: B0005-465651. Molecular formula: C29H40O8. Mole weight: 516.631. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
